ArticleFrontiers in oncology2025

Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea.

Gi-June Min et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.